Christina M Parker

Title: Christina M Parker: Innovator in Autoimmune Disease Treatment

Introduction

Christina M Parker is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of five patents to her name, Parker's work focuses on innovative methods to address complex health issues.

Latest Patents

Among her latest patents is a method for treating ulcerative colitis or Crohn's disease by administering an antibody to αEβ7 integrin. This invention relates to a method for treating autoimmune diseases characterized by lymphocyte accumulation at epithelial sites. The method involves administering an effective amount of an antibody that selectively binds to an αβ integrin or an α subunit thereof. Another notable patent involves antibodies that bind to a highly charged region of the integrin αE subunit and its functional equivalents. These antibodies are useful in screening assays to identify agents that mimic the ligand-binding site on the integrin αE.

Career Highlights

Christina M Parker is affiliated with Brigham and Women's Hospital, Inc., where she continues her research and development in the medical field. Her work has garnered attention for its potential to improve treatment options for patients suffering from autoimmune diseases.

Collaborations

Parker has collaborated with esteemed colleagues, including Michael B Brenner and Michael P Schon, who share her commitment to advancing medical science and improving patient outcomes.

Conclusion

Christina M Parker's innovative contributions to the treatment of autoimmune diseases highlight her role as a leading inventor in the medical field. Her patents reflect a dedication to improving health care and patient well-being.